狼疮肾炎维持期霉酚酸药代动力学与药物基因组学及临床相关性
在88例稳定期狼疮肾炎维持治疗患者中,每6个月重复监测霉酚酸(MPA)血药浓度,评估其与12小时AUC及ABCC2、OATP、UGT基因单核苷酸多态性的关系。C12与AUC0-12相关,且与肾脏复发、感染和贫血相关;ABCC2 rs2273697 A/G与较低MPA暴露相关。
要点
- MPA C12与AUC0-12相关,可用于维持期暴露监测。
- C12与肾脏复发、感染和贫血相关,低C12见于复发,高C12见于感染。
- ABCC2 rs2273697 A/G与较低MPA暴露相关。
核心结论
- MPA C12与AUC0-12相关,并与肾脏复发、感染和贫血相关。
- ABCC2 rs2273697 A/G与较低MPA暴露相关。
研究设计与样本
- 在88例接受泼尼松龙和霉酚酸酯维持治疗的稳定期狼疮肾炎患者中,于给药后1、2、4、8、10和12小时(C1、C2、C4、C8、C10、C12)测定血MPA水平,每6个月重复。
- 同时分析MPA暴露与ABCC2(rs2273697、rs3740066、rs717620、rs17222723)、OATP(rs7311358、rs4149117)和UGT(rs17863762、rs6714486、rs17868320、rs72551330)单核苷酸多态性的关系。
主要发现
- C1、C2和C12分别为8.3±6.6、7.2±5.2和2.0±1.4 mg/L,均与AUC0-12相关(r=0.51、0.85和0.73;P=0.02、<0.001和<0.001)。
- C12与血红蛋白、免疫球蛋白和白细胞水平呈负相关(P均<0.05)。
- 96周内发生5次肾脏复发、11次感染和10次贫血(血红蛋白<10 g/dL),对应C12分别为1.3±0.5、4.3±2.6和2.9±1.5 mg/L;无上述并发症者分别为2.4±1.2、1.8±1.2和1.7±1.1 mg/L(P=0.041、<0.001和0.004)。
- ABCC2 rs2273697 A/G与较低MPA暴露相关(1075.9±239.9 vs 1891.5±918.9 mgh/L per g/kg;P=0.003)。
- OATP和UGT的单核苷酸多态性与MPA水平无关。
临床怎么用
- 维持期可考虑监测MPA C12以评估暴露并与AUC0-12关联。
- 关注C12与肾脏复发、感染和贫血的关联,低C12时警惕复发,高C12时警惕感染。
- ABCC2 rs2273697 A/G携带者可能MPA暴露较低,需关注剂量调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is little data on mycophenolic acid (MPA) pharmacokinetics and pharmacogenomics and optimal MPA exposure in lupus nephritis (LN) patients during long-term maintenance. METHODS: We measured blood MPA levels at 1, 2, 4, 8, 10 and 12-h post-dose (i.e. C1, C2, C4, C8, C10 and C12) in 88 stable LN patients receiving maintenance prednisolone and mycophenolate mofetil, repeated every 6 months. The relationship between MPA exposure and single nucleotide polymorphisms (SNPs) of adenosine triphosphate-binding cassette subfamily C member 2 (ABCC2; rs2273697, rs3740066, rs717620 and rs17222723), organic anion-transporting polypeptides (OATPs; rs7311358 and rs4149117) and uridine diphosphate glucuronosyltransferase (UGT; rs17863762, rs6714486, rs17868320 and rs72551330) was also investigated. RESULTS: C1, C2 and C12 were 8.3 ± 6.6 , 7.2 ± 5.2 and 2.0 ± 1.4 mg/L and all correlated with the 12-h area under the curve (AUC0-12; r = 0.51, 0.85 and 0.73; P = 0.02, <0.001 and <0.001, respectively). C12 inversely correlated with hemoglobin, immunoglobulins and leukocyte levels (P < 0.05 for all). Five renal flares, 11 episodes of infection and 10 episodes of anemia (hemoglobin <10 g/dL) occurred over 96 weeks, with a corresponding C12 of 1.3 ± 0.5, 4.3 ± 2.6 and 2.9 ± 1.5 mg/L, respectively (versus 2.4 ± 1.2, 1.8 ± 1.2 and 1.7 ± 1.1 mg/L in patients without these complications; P = 0.041, <0.001 and 0.004). SNP rs2273697 A/G in the ABCC2 gene was associated with lower MPA exposure compared with G/G (1075.9 ± 239.9 versus 1891.5 ± 918.9 mgh/L per g/kg; P = 0.003). SNPs of OATP and UGT were unrelated to MPA level. CONCLUSION: MPA C12 correlates with the AUC0-12 and is related to renal flare, infection and anemia. SNP rs2273697 A/G is associated with lower MPA exposure.
引用
- Yap DYH, Tam CH, Yung S, et al. Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis. Nephrol Dial Transplant. 2020. PMID: 30215770. doi:10.1093/ndt/gfy284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。